/stocks — the workspaceLOADING
When they report, what options are priced for, and what the filings say. Back to SMCI · All filings
Estimated, not confirmed. Projected from this company’s own reporting history. We publish how often that estimator is right rather than asking you to take it on trust: see the earnings calendar.
One email before each report, every quarter, until you remove it. It goes to the email on your account.
The at-the-money straddle expiring 2027-02-19 (17 days after the report) costs $9.32 against a $28.86 share price, at the $29 strike.
This is what the market is priced for, in either direction. It is not a forecast, it carries no view on which way the stock goes, and options routinely price moves that do not happen. Quotes are delayed. Open interest: 218 calls, 257 puts.
From the results release filed 2026-11-03, read 2026-11-05. Companies report earnings per share twice: the figure the accounting rules (GAAP) define, and their own adjusted figure that leaves out items they choose. They are different measures.
No figure yet. XBRL holds no three-month diluted EPS ending in the 100 days before this release (checked 2026-11-06): the 10-Q carrying it is not filed yet, or this is a fourth quarter, which the annual report files only as part of the full year.
None read. No sentence of the release states an adjusted (non-GAAP) EPS for the quarter. Some companies report GAAP figures only.
How the adjusted figure is read: only from sentences, and only when the release states the same figure at least twice; a figure stated once, or two figures that disagree, leave the box empty. Measured 2026-11-05 on 71 results releases read by hand: it printed 39 adjusted EPS figures, all of them right, and left out 20 of the 59 the documents state, because its rules abstain rather than guess.
The last quarterly report, and what changed in it since the one before.
We do not publish consensus or “whisper” EPS estimates. Those are licensed products, and a number we cannot trace to a source is a number we will not print. Nothing here is a recommendation to buy, sell or hold SMCI.